Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33‐positive acute myeloid leukemia in first recurrence

Richard A. Larson, Matthias Theobald, Jacques J. M. van Dongen et al.|Cancer|2005

Cited by 459